Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple secondary messengers" refers to a heterogeneous group of small intracellular molecules—including cyclic AMP, cyclic GMP, inositol triphosphate, diacylglycerol, calcium ions, and certain gases—that relay and amplify signals from activated cell surface receptors to downstream effectors within the cell, implementing diverse biological functions such as proliferation, differentiation, metabolism, and apoptosis. They are not themselves considered direct therapeutic targets, but are essential components of cellular signaling cascades and common downstream nodes affected by drugs targeting receptors, enzymes, or ion channels.
Not applicable (second messengers themselves are not primary drug targets; typical mechanisms involve modulation of their *synthesis* or *degradation*, e.g., phosphodiesterase inhibitors increase cAMP/cGMP by preventing their breakdown)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple secondary messengers.